On January 18th, Modulated Imaging, Inc. announced that it received clearance from the FDA for its Ox-Imager CS technology. This device is designed to assist clinicians with the identification of lower limb vascular issues, so that patients can receive appropriate, timely treatment. With FDA authorization, Modulated Imaging can now launch the technology at clinical centers throughout the United States.
The seeds for Modulated Imaging were planted in 2002, when David Cuccia, Modulated Imaging’s CEO and CTO, then an undergraduate in Physics at UC Irvine, began exploring new light-based ways to more accurately image and measure the health of tissue. With the help of his mentors, Bruce Tromberg, Ph.D. and Anthony Durkin, Ph.D., at the Beckman Laser Institute, David developed a new imaging technique that he nicknamed “a thousand points of light,” and Spatial Frequency Domain Imaging (SFDI) was born. David was so excited about the potential of SFDI that he decided to commit himself to the project, and made SFDI the subject of his doctoral dissertation in 2006. Convinced of the value SFDI could bring to the research and medical communities, the now Dr. Cuccia worked independently to develop SFDI, and in 2008 began to build the Modulated Imaging team and start product development.
Modulated Imaging was originally housed within the Photonic Incubator at the Beckman Laser Institute at UC Irvine. In 2014, the company expanded to its first commercial space in San Juan Capistrano, and quickly outgrew this location. Today, Modulated Imaging operates in a 6,000 sq. ft. building in Irvine, California, that includes office space, and separate areas dedicated to lab research and production.
“This FDA clearance is a major milestone for our company, and for the patients and physicians within the vascular treatment communities,” said Cuccia, Ph.D. “Ox-Imager can lead to significant preventive care actions as well as an estimated potential of $6.2 billion in savingsper year. We’re proud to be able to provide meaningful information that advances patients’ health and wellness.”
This story originally appeared on Business Wire: http://www.businesswire.com/news/home/20170118006119/en/Modulated-Imaging-Receives-FDA-Clearance-Ox-Imager-CS.